Patients’ Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications

Abstract

Patients with IBD perceive biologics to be of higher benefit but riskier and more dreadful as compared with immunomodulators. Risk perception may be about more than their knowledge base but also about how much control patients typically believe they have over their daily lives.